Clearpoint Neuro Stock Price History
| CLPT Stock | USD 11.09 0.13 1.19% |
Below is the normalized historical share price chart for Clearpoint Neuro extending back to May 21, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Clearpoint Neuro stands at 11.09, as last reported on the 22nd of November, with the highest price reaching 11.19 and the lowest price hitting 10.85 during the day.
If you're considering investing in Clearpoint Stock, it is important to understand the factors that can impact its price. Clearpoint Neuro secures Sharpe Ratio (or Efficiency) of -0.0035, which signifies that the company had a -0.0035% return per unit of standard deviation over the last 3 months. Clearpoint Neuro exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clearpoint Neuro's mean deviation of 2.79, and Risk Adjusted Performance of 5.0E-4 to double-check the risk estimate we provide.
At this time, Clearpoint Neuro's Common Stock Shares Outstanding is comparatively stable compared to the past year. Total Stockholder Equity is likely to gain to about 22.2 M in 2024, whereas Capital Stock is likely to drop slightly above 213.1 K in 2024. . At this time, Clearpoint Neuro's Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 8.29 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (12.79) in 2024. Clearpoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 2020 | 200 Day MA 8.3531 | 50 Day MA 11.9424 | Beta 1.108 |
Clearpoint |
Sharpe Ratio = -0.0035
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLPT |
Estimated Market Risk
| 3.78 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Clearpoint Neuro is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Clearpoint Neuro by adding Clearpoint Neuro to a well-diversified portfolio.
Price Book 10.5484 | Enterprise Value Ebitda (7.07) | Price Sales 10.0534 | Shares Float 25.4 M | Wall Street Target Price 16.3333 |
Clearpoint Neuro Stock Price History Chart
There are several ways to analyze Clearpoint Stock price data. The simplest method is using a basic Clearpoint candlestick price chart, which shows Clearpoint Neuro price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 18, 2024 | 13.46 |
| Lowest Price | November 18, 2024 | 10.74 |
Clearpoint Neuro November 22, 2024 Stock Price Synopsis
Various analyses of Clearpoint Neuro's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Clearpoint Stock. It can be used to describe the percentage change in the price of Clearpoint Neuro from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Clearpoint Stock.| Clearpoint Neuro Price Rate Of Daily Change | 1.01 | |
| Clearpoint Neuro Price Daily Balance Of Power | 0.38 | |
| Clearpoint Neuro Price Action Indicator | 0.13 |
Clearpoint Neuro November 22, 2024 Stock Price Analysis
Clearpoint Stock Price History Data
The price series of Clearpoint Neuro for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 2.72 with a coefficient of variation of 6.41. The prices are distributed with arithmetic mean of 12.0. The median price for the last 90 days is 12.04. The company had 1:40 stock split on 27th of July 2016. Clearpoint Neuro issued dividends on 2016-07-27.| Open | High | Low | Close | Volume | ||
11/22/2024 | 11.08 | 11.19 | 10.85 | 11.09 | ||
| 11/21/2024 | 11.08 | 11.19 | 10.85 | 11.09 | 94,558 | |
| 11/20/2024 | 10.97 | 11.05 | 10.60 | 10.96 | 147,994 | |
| 11/19/2024 | 10.68 | 11.15 | 10.61 | 10.97 | 128,873 | |
| 11/18/2024 | 11.24 | 11.32 | 10.70 | 10.74 | 205,475 | |
| 11/15/2024 | 11.16 | 11.37 | 10.87 | 10.93 | 223,447 | |
| 11/14/2024 | 12.00 | 12.82 | 11.18 | 11.24 | 476,767 | |
| 11/13/2024 | 11.23 | 11.36 | 10.81 | 10.95 | 248,660 | |
| 11/12/2024 | 11.32 | 11.45 | 10.94 | 11.12 | 341,027 | |
| 11/11/2024 | 12.20 | 12.23 | 11.26 | 11.41 | 316,188 | |
| 11/08/2024 | 12.51 | 12.95 | 10.15 | 11.65 | 701,864 | |
| 11/07/2024 | 13.30 | 13.86 | 13.15 | 13.42 | 362,309 | |
| 11/06/2024 | 13.25 | 13.42 | 12.74 | 13.38 | 348,736 | |
| 11/05/2024 | 12.69 | 12.91 | 12.39 | 12.82 | 112,701 | |
| 11/04/2024 | 12.77 | 13.07 | 12.56 | 12.74 | 82,967 | |
| 11/01/2024 | 12.57 | 13.09 | 12.37 | 12.89 | 178,909 | |
| 10/31/2024 | 12.79 | 12.85 | 12.04 | 12.39 | 158,883 | |
| 10/30/2024 | 12.87 | 13.24 | 12.54 | 12.86 | 140,078 | |
| 10/29/2024 | 13.03 | 13.30 | 12.68 | 13.02 | 176,440 | |
| 10/28/2024 | 13.14 | 13.70 | 13.06 | 13.15 | 190,173 | |
| 10/25/2024 | 12.78 | 13.14 | 12.27 | 13.04 | 248,894 | |
| 10/24/2024 | 12.29 | 12.84 | 12.20 | 12.58 | 129,271 | |
| 10/23/2024 | 12.72 | 12.95 | 11.99 | 12.29 | 219,143 | |
| 10/22/2024 | 13.13 | 13.46 | 12.50 | 12.79 | 191,358 | |
| 10/21/2024 | 13.60 | 13.60 | 12.68 | 13.23 | 223,528 | |
| 10/18/2024 | 12.08 | 14.13 | 12.06 | 13.46 | 989,050 | |
| 10/17/2024 | 12.14 | 12.23 | 11.63 | 12.06 | 120,890 | |
| 10/16/2024 | 12.16 | 12.43 | 11.98 | 11.98 | 161,448 | |
| 10/15/2024 | 12.43 | 12.43 | 11.44 | 12.04 | 230,676 | |
| 10/14/2024 | 11.63 | 12.43 | 11.57 | 12.41 | 494,037 | |
| 10/11/2024 | 11.33 | 11.78 | 11.23 | 11.61 | 121,877 | |
| 10/10/2024 | 11.93 | 11.97 | 11.23 | 11.39 | 125,409 | |
| 10/09/2024 | 11.73 | 12.40 | 11.70 | 12.13 | 181,397 | |
| 10/08/2024 | 10.76 | 11.66 | 10.66 | 11.62 | 203,034 | |
| 10/07/2024 | 11.21 | 11.23 | 10.70 | 10.80 | 100,036 | |
| 10/04/2024 | 11.21 | 11.49 | 11.02 | 11.21 | 54,590 | |
| 10/03/2024 | 10.86 | 11.23 | 10.75 | 11.12 | 76,164 | |
| 10/02/2024 | 10.84 | 11.01 | 10.68 | 10.91 | 119,298 | |
| 10/01/2024 | 11.28 | 11.28 | 10.81 | 10.81 | 89,603 | |
| 09/30/2024 | 11.09 | 11.27 | 10.94 | 11.21 | 158,650 | |
| 09/27/2024 | 11.08 | 11.36 | 10.96 | 11.19 | 101,534 | |
| 09/26/2024 | 11.51 | 11.51 | 10.91 | 11.11 | 146,044 | |
| 09/25/2024 | 11.40 | 11.42 | 11.15 | 11.27 | 97,048 | |
| 09/24/2024 | 11.65 | 11.76 | 11.02 | 11.40 | 173,618 | |
| 09/23/2024 | 12.39 | 12.39 | 11.41 | 11.53 | 209,061 | |
| 09/20/2024 | 12.27 | 12.40 | 11.81 | 12.40 | 219,397 | |
| 09/19/2024 | 12.00 | 12.14 | 11.74 | 12.14 | 116,340 | |
| 09/18/2024 | 11.76 | 12.16 | 11.56 | 11.66 | 223,347 | |
| 09/17/2024 | 12.58 | 12.68 | 11.66 | 11.92 | 240,479 | |
| 09/16/2024 | 12.67 | 12.98 | 11.81 | 12.40 | 222,443 | |
| 09/13/2024 | 12.10 | 13.04 | 11.77 | 12.59 | 366,124 | |
| 09/12/2024 | 12.08 | 12.43 | 12.03 | 12.18 | 110,278 | |
| 09/11/2024 | 12.09 | 12.33 | 11.44 | 12.21 | 120,247 | |
| 09/10/2024 | 12.00 | 12.06 | 11.51 | 12.06 | 138,088 | |
| 09/09/2024 | 11.88 | 12.50 | 11.76 | 11.84 | 108,225 | |
| 09/06/2024 | 12.45 | 12.57 | 11.35 | 11.89 | 231,763 | |
| 09/05/2024 | 12.43 | 12.56 | 12.00 | 12.35 | 108,062 | |
| 09/04/2024 | 12.52 | 12.89 | 12.42 | 12.46 | 83,493 | |
| 09/03/2024 | 12.83 | 12.99 | 12.44 | 12.62 | 175,975 | |
| 08/30/2024 | 13.41 | 13.47 | 12.75 | 12.98 | 174,493 | |
| 08/29/2024 | 12.56 | 13.37 | 12.56 | 13.18 | 160,760 |
About Clearpoint Neuro Stock history
Clearpoint Neuro investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Clearpoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Clearpoint Neuro will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Clearpoint Neuro stock prices may prove useful in developing a viable investing in Clearpoint Neuro
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.6 M | 25.8 M | |
| Net Loss | -14.8 M | -14.1 M |
Clearpoint Neuro Quarterly Net Working Capital |
|
Clearpoint Neuro Stock Technical Analysis
Clearpoint Neuro technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Clearpoint Neuro Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Clearpoint Neuro's price direction in advance. Along with the technical and fundamental analysis of Clearpoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Clearpoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 5.0E-4 | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.54) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.